Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc..
October 23, 2022
Share
Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc. (NasdaqCM:BIMI) on October 24, 2022. The closing of the Agreement is expected to take place late in the fourth quarter of 2022, subject to necessary regulatory approvals.
BIMI Holdings Inc., formerly BIMI International Medical Inc., is a healthcare products and services provider. The Company offers a range of healthcare products and related services in the United States and Asia. The Company operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.